Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Frontiers in Immunology|February 20, 2019
Recombinant Sialyltransferase Infusion Mitigates Infection-Driven Acute Lung InflammationMehrab Nasirikenari, Amit A Lugade, Sriram Neelamegham, et al.
Gynecologic Oncology|April 11, 2017
NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancerJ Brian Szender, Antonios Papanicolau-Sengos, Kevin H Eng, et al.
Journal of Leukocyte Biology|December 17, 2009
Altered eosinophil profile in mice with ST6Gal-1 deficiency: an additional role for ST6Gal-1 generated by the P1 promoter in regulating allergic inflammationMehrab Nasirikenari, E V Chandrasekaran, Khushi L Matta, et al.
American Journal of Clinical Oncology|March 26, 2016
Efficacy, Safety, and Potential Biomarkers of Sunitinib and Transarterial Chemoembolization (TACE) Combination in Advanced Hepatocellular Carcinoma (HCC): Phase II TrialVenkata K Pokuri, Garin M Tomaszewski, Sihem Ait-Oudhia, et al.
Journal for Immunotherapy of Cancer|July 19, 2019
Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancerA J Robert McGray, Ruea-Yea Huang, Sebastiano Battaglia, et al.
Frontiers in Immunology|May 24, 2021
IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells via Aryl Hydrocarbon Receptor ActivationAdaobi Amobi-McCloud, Ravikumar Muthuswamy, Sebastiano Battaglia, et al.
Oncotarget|July 18, 2020
Clonality and antigen-specific responses shape the prognostic effects of tumor-infiltrating T cells in ovarian cancerTakemasa Tsuji, Kevin H Eng, Junko Matsuzaki, et al.
Journal for Immunotherapy of Cancer|June 22, 2019
Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancerSong Liu, Junko Matsuzaki, Lei Wei, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|September 9, 2020
Circulating CD14+ HLA-DRlo/- monocytic cells as a biomarker for epithelial ovarian cancer progressionAshley E Stenzel, Scott I Abrams, Janine M Joseph, et al.
Science Translational Medicine|March 16, 2022
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responsesKunle Odunsi, Feng Qian, Amit A Lugade, et al.
Pageof 3